论文部分内容阅读
The prognosis for patients with primarymalignant glioma remains poor, in spite of a varietyof different forms of treatments. Broad suppressionof humoral and cell-mediated immunity is found inpatients with malignant gliomas. Interleukin-2 (IL-2)production and IL-2 receptor expression are decreased
The prognosis for patients with primary malignant glioma remains poor, in spite of a variety of different forms of treatments. Broad suppression of humoral and cell-mediated immunity is found in patients with malignant gliomas. Interleukin-2 (IL-2) production and IL- are decreased